Stories
Ashton lab spinoff safeguards developing brain, spinal cord from toxic threats
Randolph Ashton, an associate professor of biomedical engineering, is co-founder of Neurosetta, a startup company built around technology for modeling human brain and spinal cord development that emerged from his research lab.
How Zombies Can Help Prevent the Next Pandemic
Incomplete viral genomes can quell disease and, with further research, could be turned into treatments. An opinion by John Yin for Scientific American.
Madison startup developing chemical health testing platform
WID's Randolph Ashton is developing a method for “scalable and cost-effective screening” of various chemical compounds on the brain and spinal cord. The new company is Neurosetta.
How Does Life Begin?
PhD student Lena Vincent pursues the biggest question in her research on the chemical origins of life.
Announcements
Newsletters
Follow Us
Learn more about the Wisconsin Institute for Discovery through quarterly newsletters and receive our annual report.
